Atherosclerosis and Cardiovascular Diseases: Proceedings of the Sixth International Meeting on Atherosclerosis and Cardiovascular Diseases held in Bologna, Italy, October 27–29,1986

Front Matter....Pages i-xviii
Evaluation of the clinical significance of the discovery of the LDL receptor....Pages 1-11
Social aspects of atherosclerosis....Pages 13-40
Primary and secondary prevention of atherosclerosis and coronary heart disease....Pages 41-48
The “CNR Progetto Finalizzato Obiettivo 44 Progression e/o regression” an update on studies in Italy....Pages 49-54
Atherosclerosis and the CNR Progetto Finalizzato “Medicina Preventiva e Riabilitativa”....Pages 55-67
Cardiac and vascular surgery: results, perspectives and hopes....Pages 69-72
Front Matter....Pages 73-73
Genetic basis of apolipoprotein disorders....Pages 75-79
Apolipoproteins in differential diagnosis of patients at high risk for atherosclerosis....Pages 81-87
Genetic and non-genetic control of apoprotein....Pages 89-92
The plasma metabolism of apolipoprotein A-IV....Pages 93-96
Modified LDL in humans....Pages 97-100
Clinical aspects of lipoprotein disorders....Pages 101-107
Front Matter....Pages 109-109
Fixed versus dynamic stenosis: possible causes and therapeutic approach....Pages 111-115
The epicardial coronary arteries at necropsy in acute myocardial infarction....Pages 117-124
Perspectives in the management of acute myocardial infarction....Pages 125-132
Atherosclerosis and ischaemic heart disease: surgical solutions....Pages 133-138
Front Matter....Pages 139-139
Effects of calcium antagonists and adrenergic antihypertensive drugs on cellular cholesterol metabolism....Pages 141-147
Blood platelets: their role in atherogenesis and arterial thrombosis and their inhibition, in particular by calcium antagonists....Pages 149-154
Front Matter....Pages 155-155
Prevention of coronary heart disease - links with other chronic disorders....Pages 157-162
Therapy versus prevention of coronary heart disease....Pages 163-170
Front Matter....Pages 155-155
Prevention in Europe - facts, fallacies and future....Pages 171-179
Low linoleic acid - a new risk factor for coronary heart disease....Pages 181-185
The US National Cholesterol Education Program....Pages 188-192
The WHO European Multifactor Preventive Trial of CHD....Pages 193-198
Epidemiology and clinical features of hypertension in the elderly....Pages 199-203
Atherosclerosis precursors in children. The Bologna study. Preliminary data....Pages 205-213
From observational to intervention programmes. The Brisighella study....Pages 215-221
Front Matter....Pages 223-223
Relationship of glucose intolerance and elevated triglyceride: implications for gemfibrozil....Pages 225-229
A comparison of different formulations and dosage administrations of gemfibrozil in types IIA and IIB hyperlipidemia....Pages 231-235
Coronary heart disease in Italy....Pages 237-243
Front Matter....Pages 245-245
Dietary fiber and lipid metabolism....Pages 247-251
Dietary and biochemical studies with textured soy proteins....Pages 253-259
Fats from marine animals in human nutrition and prevention of cardiovascular diseases....Pages 261-267
The influence of diet and drugs of cholesterol metabolism in the liver....Pages 269-271
Individuality of the response of serum cholesterol to dietary cholesterol....Pages 273-278
Familial hypercholesterolemia in Italy; plasma cholesterol evaluation and diagnostic insight....Pages 279-286
Front Matter....Pages 287-287
Do atherosclerotic plaques regress spontaneously in humans?....Pages 289-294
Pathogenetic mechanisms of transient brain ischaemic attacks....Pages 295-302
Interrelations between the degree of lipid lowering effect and the rate of progression of atherosclerotic cardiovascular disease....Pages 303-308
Results of carotid endarterectomy....Pages 309-315
Front Matter....Pages 317-317
Haemostatic factors and lipoproteins in atherogenesis....Pages 319-325
Comparative evaluation of echographic and histomorphometric data of carotid endarterectomy samples....Pages 327-330
Correlative electron microscopy in the study of atherosclerosis....Pages 331-336
The role of oxygen free radicals in the ischaemia - reperfusion injury....Pages 337-346
Local and remote effects of acute ischaemic infarction on cerebral glucose metabolism in man....Pages 347-350
Front Matter....Pages 351-351
Serotonin and cardiovascular disease....Pages 353-359
Ketanserin in the treatment of hypertension: clinical review....Pages 361-366
Platelets and platelet-related substances in the natural history of atherosclerosis. The role of serotonin....Pages 367-373
Prevalence and incidence of leg ischaemia in the general population....Pages 375-380
Front Matter....Pages 381-381
Dynorphin-related peptides in central and peripheral tissues: distribution and possible functions....Pages 383-387
Aging brain and dementia: change in central opioids and ACTH....Pages 389-394
Relationship between endogenour opioids and the cardiovascular system: dynorphin measurement in the human heart: β-endorphin plasmatic levels assay during acute pulmonary oedema....Pages 395-398
Front Matter....Pages 399-399
Studies on DNA fragment length polymorphism of human apolipoprotein B gene....Pages 401-408
Porphyrins, tumors and atherosclerosis....Pages 409-414
Influence of physical exercise on plasma lipoprotein pattern in healthy subjects....Pages 415-423
Long-term experience with bezafibrate in different types of hyperlipidemia....Pages 425-430
Role of fibrinogen in atherosclerosis: therapeutic effects of bezafibrate in short-term treatment....Pages 431-437
Front Matter....Pages 439-439
Effects of Acipimox on in vivo insulin sensitivity in obese subjects and NID diabetics....Pages 441-446
The lipid-lowering effect of the acipimox: comparison with tiadenol and probucol....Pages 447-454
A controlled trial on the hypolipidemic effect of Acipimox in type IIA and IIB hyperlipoproteinemia....Pages 455-461
Front Matter....Pages 439-439
Effect of Acipimox on serum lipids and apoproteins in type II hyperlipoproteinemia....Pages 463-467
Long-term multicentre trial with acipimox in diabetic patients with hyperlipoproteinemia....Pages 469-472
Front Matter....Pages 473-473
Experimental pharmacological aspects in brain aging....Pages 475-481
Acute effects of L-acetylcarnetine (LAC) on quantitative EEG (QEEG) and visual evoked potentials (VEPS) in patients affected by senile, presenile and alcoholic dementia. Comparison with L-carne tine....Pages 483-489
The pharmacology of cognitive disturbances: Problems and perspectives....Pages 491-496
L-Acetylcarnetine prevents the parkinsonian syndrome induced by MPTP in monkeys....Pages 497-504
Front Matter....Pages 505-505
Nuclear magnetic resonance in the detection of the atherosclerotic lesion....Pages 507-512
Perspective and limits of emission tomography in cerebrovascular disorders....Pages 513-521
The real utility of nuclear magnetic resonance in cardiovascular diseases....Pages 523-528
B-Mode echography: a new approach to the epidemiology of atherosclerotic disease?....Pages 529-534
Cardiac doppler in the assessment of aortic valvular diseases....Pages 535-541
Myocardial ischemia in pediatric age: clinical pictures and non-invasive assessment....Pages 543-549
Extracranial carotid atherosclerosis evolution and stroke occurrence: Role of the echotomographic analysis....Pages 551-556
Pre- and post-operative echotomography and aortic endoarterectomy....Pages 557-563
Back Matter....Pages 565-571